CI
CIPLA
CIPLA Cipla Q4 FY25 results (Jan–Mar 2025) and concall
FY25 marked a year of historic achievements for Cipla with multiple business milestones across geographies. The company demonstrated operational excellence through successful FDA inspections while building a robust pipeline for future growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 |
|---|---|---|
| Revenue | 4,971 | 4,798 |
| EBITDA | 1,662 | 1,319 |
| Net profit | 1,438 | 1,485 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
